Stonegate Capital Partners has initiated coverage on HyOrc Corporation (OTCQB: HYOR), a company focused on converting refuse-derived fuel (RDF) into green methanol. The announcement, made July 29, 2026, highlights HyOrc's technology that transforms prepared municipal and industrial waste into synthesis gas, which is then cleaned and converted into methanol via a catalytic synthesis process. Stonegate views the core equity story as less about broad clean-tech exposure and more about whether HyOrc can transition from pilot and equipment-delivery history to commercial-scale methanol production.
HyOrc targets green methanol production at approximately €350 per tonne, significantly lower than the conventional grey methanol benchmark of about €850 per tonne. However, Stonegate notes that the company must still prove these economics in continuous commercial operation. The clearest near-term commercial validation is the planned shipment of HyOrc's fully funded initial 1 tonne per day (TPD) Porto methanol module in September 2026, which represents the first step toward an 8 TPD facility in Portugal. Once installed and operated, this facility will serve as a critical proof point.
Beyond methanol, HyOrc is developing external-combustion power systems for stationary generation and locomotive retrofits. The delivery of two 500 kW turbine units and a memorandum of understanding with GB Railfreight provide early reference points, although both opportunities remain ahead of full commercial deployment. Stonegate's coverage suggests that while HyOrc has promising technology and initial project momentum, investors should monitor the company's ability to achieve continuous commercial operations and cost targets.
For more details, the full announcement is available here. Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Its affiliate, Stonegate Capital Markets (member FINRA), offers investment banking, equity research, and capital raising for public and private companies.
